Montag & Caldwell’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
Montag & Caldwell's CELG Position: Q4 2017 in Review
Montag & Caldwell sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 743,460 shares — an estimated $108M sold.
Montag & Caldwell first reported a position in CELG in Q2 2015 and held it in 10 quarters. The position peaked at $217M in Q4 2015. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.
- Montag & Caldwell reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
- Montag & Caldwell sold 743,460 Celgene Corp shares in Q4 2017, an estimated $108M.
- Montag & Caldwell first reported a position in Celgene Corp in Q2 2015 and held it in 10 quarters.
- Montag & Caldwell's Celgene Corp position peaked at $217M in Q4 2015.
- 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.
Based on Montag & Caldwell's 13F filing for Q4 2017, filed 1 Feb 2018.